International Clinical Trial: Efficacy of Fecal Microbiota Transplantation in Preventing Hepatic Encephalopathy Recurrence: A Prospective, Double-Blind, Randomized Controlled Trial

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115448) titled 'Efficacy of Fecal Microbiota Transplantation in Preventing Hepatic Encephalopathy Recurrence: A Prospective, Double-Blind, Randomized Controlled Trial' on Dec. 26, 2025.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Beijing You An Hospital, Capital Medical University

Condition: Hepatic Encephalopathy

Intervention: Control Group:Oral rifaximin combined with lactulose everyday Single-dose FMT Treatment Group:Oral rifaximin combined with lactulose everyday Take 4 oral FMT capsules per dose, twice daily, for 6 consecutive days during the first week. Two-dose FMT Treatment Group:Oral ...